ArticleMolecules (Basel, Switzerland)2024

Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors.

Dominik Straszak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.